A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8+ T-cell accumulation in the skin

Journal of Investigative Dermatology

Volumn 132, Issue 7, 2012, Pages 1869-1876

  Harris, John E ^a   Harris, Tajie H ^b   Weninger, Wolfgang ^c,d   Wherry, E John ^e   Hunter, Christopher A ^b   Turka, Laurence A ^f  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

^c CENTENARY INSTITUTE   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DEPIGMENTATION; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VITILIGO;

EID: 84862318378     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.463     Document Type: Article

References (23)

1. Ahn SK, Choi EH, Lee SH et al. (1994) Immunohistochemical studies from vitiligo - comparison between active and inactive lesions. Yonsei Med J 35:404-10
2. Andersen MH, Schrama D, Thor Straten P et al. (2006) Cytotoxic T cells. J Invest Dermatol 126:32-41 (Pubitemid 43336091)
3. Antony PA, Piccirillo CA, Akpinarli A et al. (2005) CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol 174:2591-601 (Pubitemid 40279672)
4. Becker JC, Varki N, Brocker EB et al. (1996) Lymphocyte-mediated alopecia in C57BL/6 mice following successful immunotherapy for melanoma. J Invest Dermatol 107:627-32 (Pubitemid 26338591)
5. Bromley SK, Mempel TR, Luster AD (2008) Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat Immunol 9:970-80
6. Elso CM, Roberts LJ, Smyth GK et al. (2004) Leishmaniasis host response loci (lmr1-3) modify disease severity through a Th1/Th2-independent pathway. Genes Immun 5:93-100 (Pubitemid 38967637)
7. Falabella R (2009) Vitiligo and the melanocyte reservoir. Indian J Dermatol 54:313-8
8. Friedl P, Weigelin B (2008) Interstitial leukocyte migration and immune function. Nat Immunol 9:960-9
9. Gilhar A, Landau M, Assy B et al. (2001) Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice. J Invest Dermatol 117:1357-62 (Pubitemid 34032760)
10. Gilhar A, Paus R, Kalish RS (2007) Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 117:2019-27 (Pubitemid 47219540)
11. Gregg RK, Nichols L, Chen Y et al. (2010) Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. J Immunol 184:1909-17
12. Kunisada T, Lu SZ, Yoshida H et al. (1998) Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor. J Exp Med 187:1565-73 (Pubitemid 28235098)
13. Majumdar MK, Feng L, Medlock E et al. (1994) Identification and mutation of primary and secondary proteolytic cleavage sites in murine stem cell factor cDNA yields biologically active, cell-associated protein. J Biol Chem 269:1237-42
14. Marelli-Berg FM, Jarmin SJ (2004) Antigen presentation by the endothelium: a green light for antigen-specific T cell trafficking? Immunol Lett 93:109-13 (Pubitemid 38670362)
15. Mrass P, Takano H, Ng LG et al. (2006) Random migration precedes stable target cell interactions of tumor-infiltrating T cells. J Exp Med 203:2749-61 (Pubitemid 44833350)
16. Ogg GS, Rod Dunbar P, Romero P et al. (1998) High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med 188:1203-8 (Pubitemid 28443344)
17. Overwijk WW, Theoret MR, Finkelstein SE et al. (2003) Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J Exp Med 198:569-80 (Pubitemid 37040391)
18. Overwijk WW, Tsung A, Irvine KR et al. (1998) gp100/pmel 17 is a murine tumor rejection antigen: induction of 'self'-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J Exp Med 188:277-86 (Pubitemid 28357756)
19. Suffia I, Reckling SK, Salay G et al. (2005) A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J Immunol 174:5444-55 (Pubitemid 40593184)
20. Taieb A, Picardo M (2009) Clinical practice. Vitiligo. N Engl J Med 360:160-9
21. van den Boorn JG, Konijnenberg D, Dellemijn TA et al. (2009) Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 129:2220-32
22. Wankowicz-Kalinska A, van den Wijngaard RM, Tigges BJ et al. (2003) Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest 83:683-95 (Pubitemid 36618047)
23. Zhang SY, Boisson-Dupuis S, Chapgier A et al. (2008) Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Immunol Rev 226:29-40